Production of TNFα by LPS-stimulated murine, rat and human blood and its pharmacological modulation

Publisher Website
Google Scholar
Abstract
Tumour necrosis factorα (TNFα) has been reported to play a key role in the pathogenesis of sepsis and chronic inflammatory diseases, including rheumatoid arthritis and atherosclerosis, suggesting that agents which inhibit TNFα production may have therapeutic utility for the treatment of such conditions. Production of TNFα by LPS (lipopolysaccharide)-stimulated murine, rat and human heparinized blood was investigated. LPS (1–100 μg/ml) caused a similar concentration- and time-dependent stimulation of TNFα production by rat and human blood, achieving levels of 750–5000 U/ml (L929 bioassay) at 6h. In contrast, TNFα production by LPS-stimulated murine blood was poor and variable (0–150 U/ml). Dexamethasone and pentoxifylline caused a concentration-dependent inhibition of TNFα production by LPS-stimulated human and rat blood with IC50s of 0.26±0.05 and 73.0±26.4 μM for human and 5.7±1.8 nM and 20.6±8.0 μM for rat blood, respectively. Therefore, LPS-stimulated rat and human, but not murine, blood are suitable systems for the detection and evaluation of inhibitors of TNFα production.